Palmedo Philip F 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Apr 26, 2021
Insider Transaction Report
Form 4
Palmedo Philip F
Director
Transactions
- Exercise/Conversion
Common Stock
2021-04-22$0.72/sh+75,000$54,000→ 107,056 total
Holdings
- (indirect: BY PHILIP PALMEDO L.P.)
Common Stock
Footnotes (1)
- [F1]The Reported Person exercised an option to purchase 75,000 shares.